Velafaxine and Anxiety Disorders
Authors:
V. Novotný
Authors‘ workplace:
Psychiatrická klinika LF UK a FNsP, Bratislava
prednosta prof. MUDr. V. Novotný, CSc.
Published in:
Čes. a slov. Psychiat., 102, 2006, No. 4, pp. 204-209.
Category:
Comprehensive Reports
Overview
In this article is review about the studies with venlafaxine in patients with anxiety disorders. There are reviewed mostly randomized, double-blinded, placebo- controlled studies, or with active comparator-controlled. Venlafaxine is effective in anxiety disorders. It exists as good evidence for generalised anxiety disorder (GAD) and social anxiety disorder (SAD). In the case of social anxiety disorder is also a representative study in children. Federal Drug Administration had approved indication of venlafaxine for GAD and SAD. In another anxiety disorders the evidence is not sufficient.
Key words:
venlafaxine, anxiety disorders, short- term and long-term studies, effectiveness.
Labels
Addictology Paediatric psychiatry PsychiatryArticle was published in
Czech and Slovak Psychiatry
2006 Issue 4
Most read in this issue
- Velafaxine and Anxiety Disorders
- Sexual Abuse and Rape Experiences in Female Schizophrenic Patients
- Remission – a New Tool for Assessment of Treatment Efficacy
- Place and Value of Electroencephalography in Current Psychiatry